Seekyo is a biotechnology company developing a Tumor Micro Environment Targeting "Smart Chemotherapy" :
Selective to tumors, safe for patients.
We aim at a high selectivity in the treatment for solid tumors, boosting efficacy while reducing adverse effects.
We aim at improving patients’ Quality of Life.
Selective to tumors, safe for patients.
We aim at a high selectivity in the treatment for solid tumors, boosting efficacy while reducing adverse effects.
We aim at improving patients’ Quality of Life.
Location: France, New Aquitaine, Chasseneuil-du-Poitou
Employees: 1-10
Total raised: $887.72K
Founded date: 2018
Investors 1
| Date | Name | Website |
| 03.03.2021 | Business A... | business-a... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.01.2020 | Seed | $887.72K | - |
Mentions in press and media 4
| Date | Title | Description |
| 26.10.2020 | 21 start-ups reach EIT Health Catapult Final | Twenty-one start-ups from across Europe have secured their places at the EIT Health Catapult Final in December. The EIT Health Catapult, currently in its fifth year, is a training and competition programme that boosts the development of Eu... |
| 13.06.2020 | 42 start-ups reach EIT Health Catapult Semi-finals | The EIT Health Catapult, currently in its fifth year of operation, is a training and competition programme that boosts the development of European health start-ups by exposing them to top quality experts and international investors. The 42... |
| 20.01.2020 | Seekyo Raises €800k in Seed Funding | Seekyo, a Poitiers, France-based biotech startup specializing in the development of the next generation of chemotherapies, raised €800k in funding. Backers included the French Tech Seed Fund and investors from the BAdGE, INVESTESSOR and SYN... |
| 20.01.2020 | French biotech Seekyo raises €800,000 to test its tumor-targeting smart chemotherapy | Seekyo, a Poitiers-based biotech startup developing new chemotherapies, has raised €800,000 in seed funding to validate its flagship tumor-targeting drug. The financing consists of €400,000 from angel investors in the BAdGE, Investessor, an... |